The Congressional Research Service launched its new public portal this morning, with an initial installment of 628 reports dating back to January of this year. The back catalog of older reports is supposed to be added over time.
The public versions of the reports are lightly redacted to remove the author’s contact information, and to add some boilerplate language about CRS.
At this point, CRS is only posting its primary “R series” reports, such as these newly updated documents (provided here in their original, unmodified format):
American War and Military Operations Casualties: Lists and Statistics, updated September 14, 2018
Congressional Primer on Responding to Major Disasters and Emergencies, updated September 13, 2018
“In keeping with our desire to engage users with the Library and its materials,” wrote Librarian of Congress Carla Hayden, “we are happy to see these reports put to the widest use possible.”
But other CRS product lines — including CRS In Focus, CRS Insight, and CRS Legal Sidebar — are not currently available through the public portal. So CRS reports like these must still be obtained independently:
Greenhouse Gas Emissions and Sinks in U.S. Agriculture, CRS In Focus, September 17, 2018
Hurricane Florence: Brief Overview of FEMA Programs and Resources, CRS Insight, updated September 13, 2018
Locomotive Idling, Air Quality, and Blocked Crossings, CRS In Focus, updated September 13, 2018
The new public collection of CRS reports was created in response to legislation “ending the legal requirement prohibiting CRS from providing its products to the public,” according to CRS.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.